8-K · 2026-11-09
Editas Medicine reports Q3 results, highlighting progress in gene editing with new clinical trial approval for EDIT-401 and strong cash position.
| Name | Editas Medicine, Inc. |
|---|---|
| CIK | 0001650664 |
| Tickers | EDIT |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 464097528 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 617-401-9000 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Editas Medicine reports Q3 results, highlighting progress in gene editing with new clinical trial approval for EDIT-401 and strong cash position.
Editas Medicine, Inc. filed an 8-K revealing approval for a clinical trial of EDIT-401, a gene editing treatment for hyperlipidemia, on October 8, 2026.
733 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-13 | 4 | FORM 4 | 0001650664-26-000105 | 5506 | ||||||
| 2026-11-13 | 4 | FORM 4 | 0001650664-26-000104 | 5484 | ||||||
| 2026-11-09 | 10-Q | 10-Q | 0001650664-26-000103 | 001-37687 | 261536011 | 34 | 7854115 | 1 | 1 | |
| 2026-11-09 | 8-K | 8-K | 2.02,9.01 | 0001650664-26-000100 | 001-37687 | 261533770 | 34 | 326537 | 1 | 1 |
| 2026-11-06 | 4 | FORM 4 | 0001985604-26-000005 | 4845 | ||||||
| 2026-11-06 | 4 | FORM 4 | 0001742084-26-000005 | 4864 | ||||||
| 2026-10-27 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-003773 | 005-89319 | 261491620 | 34 | 10838 | |||
| 2026-10-08 | 8-K | 8-K | 7.01,8.01,9.01 | 0001650664-26-000093 | 001-37687 | 261448289 | 34 | 292599 | 1 | 1 |
| 2026-09-09 | 4 | FORM 4 | 0002149618-26-000006 | 5563 | ||||||
| 2026-09-09 | 3 | FORM 3 | 0002149618-26-000005 | 11562 | ||||||
| 2026-09-09 | S-8 | S-8 | 0001650664-26-000090 | 333-298828 | 261368404 | 33 | 218529 | 1 | 1 | |
| 2026-09-08 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-002915 | 333-298665 | 261366521 | 33 | 1713 | ||
| 2026-09-04 | 4 | FORM 4 | 0001985604-26-000003 | 5593 | ||||||
| 2026-09-04 | 4 | FORM 4 | 0002063082-26-000006 | 5017 | ||||||
| 2026-09-04 | 4 | FORM 4 | 0001742084-26-000003 | 5615 | ||||||
| 2026-08-31 | S-3 | S-3 | 0001104659-26-103906 | 333-298665 | 261346875 | 33 | 2105636 | 1 | 1 | |
| 2026-08-31 | 144 | xsl144X01/primary_doc.xml | 0001650664-26-000087 | 001-37687 | 261346578 | 33 | 4874 | |||
| 2026-08-31 | 144 | xsl144X01/primary_doc.xml | 0001650664-26-000085 | 001-37687 | 261346550 | 33 | 5375 | |||
| 2026-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-097420 | 005-89319 | 261284491 | 34 | 14716 | |||
| 2026-08-07 | 4 | FORM 4 | 0002137699-26-000004 | 5420 | ||||||
| 2026-08-07 | 3 | FORM 3 | 0002137699-26-000003 | 446678 | ||||||
| 2026-08-05 | 4 | FORM 4 | 0002063082-26-000003 | 5013 | ||||||
| 2026-08-05 | 10-Q | 10-Q | 0001650664-26-000083 | 001-37687 | 261243354 | 34 | 6276831 | 1 | 1 | |
| 2026-08-05 | 8-K | 8-K | 2.02,5.02,9.01 | 0001650664-26-000082 | 001-37687 | 261243261 | 34 | 323398 | 1 | 1 |
| 2026-07-29 | 4 | FORM 4 | 0001650664-26-000076 | 5119 | ||||||
| 2026-07-29 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-002798 | 005-89319 | 261216845 | 34 | 10887 | |||
| 2026-07-21 | 144 | xsl144X01/primary_doc.xml | 0001650664-26-000074 | 001-37687 | 261190665 | 33 | 4789 | |||
| 2026-06-22 | 4 | FORM 4 | 0001650664-26-000072 | 5428 | ||||||
| 2026-06-22 | 4 | FORM 4 | 0001650664-26-000071 | 5393 | ||||||
| 2026-06-22 | 4 | FORM 4 | 0001650664-26-000070 | 5391 | ||||||
| 2026-06-22 | 4 | FORM 4 | 0001650664-26-000069 | 5353 | ||||||
| 2026-06-22 | 4 | FORM 4 | 0001650664-26-000068 | 5396 | ||||||
| 2026-06-18 | 8-K | 8-K | 5.07 | 0001650664-26-000063 | 001-37687 | 261103146 | 34 | 159544 | 1 | 1 |
| 2026-06-05 | 4 | FORM 4 | 0001650664-26-000057 | 5480 | ||||||
| 2026-06-05 | 4 | FORM 4 | 0001650664-26-000056 | 5611 | ||||||
| 2026-06-05 | 4 | FORM 4 | 0001650664-26-000055 | 5589 | ||||||
| 2026-06-03 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001346824-26-000168 | 005-89319 | 261061573 | 34 | 18746 | |||
| 2026-06-03 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-255480 | 005-89319 | 261060854 | 34 | 124416 | |||
| 2026-06-02 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001831942-26-000027 | 005-89319 | 261057947 | 34 | 15612 | |||
| 2026-05-29 | 144 | xsl144X01/primary_doc.xml | 0001650664-26-000052 | 001-37687 | 261045420 | 33 | 4872 | |||
| 2026-05-26 | 424B5 | 424B5 | 0001104659-26-066382 | 333-277471 | 261021279 | 33 | 723830 | |||
| 2026-05-26 | 8-K | FORM 8-K | 1.01,8.01,9.01 | 0001104659-26-066317 | 001-37687 | 261020594 | 34 | 739833 | 1 | 1 |
| 2026-05-26 | S-3MEF | S-3MEF | 0001104659-26-066034 | 333-296213 | 261016043 | 33 | 225679 | 1 | 1 | |
| 2026-05-26 | 8-K | FORM 8-K | 8.01 | 0001104659-26-066021 | 001-37687 | 261015998 | 34 | 187514 | 1 | 1 |
| 2026-05-26 | 424B5 | 424B5 | 0001104659-26-065944 | 333-277471 | 261015856 | 33 | 737858 | |||
| 2026-05-26 | 8-K | FORM 8-K | 7.01,8.01,9.01 | 0001104659-26-065908 | 001-37687 | 261015823 | 34 | 227023 | 1 | 1 |
| 2026-05-14 | 8-K | 8-K | 7.01,8.01,9.01 | 0001650664-26-000049 | 001-37687 | 26975704 | 34 | 204913 | 1 | 1 |
| 2026-05-05 | 10-Q | 10-Q | 0001650664-26-000045 | 001-37687 | 26943442 | 34 | 5074561 | 1 | 1 | |
| 2026-05-05 | 8-K | 8-K | 2.02,9.01 | 0001650664-26-000043 | 001-37687 | 26940381 | 34 | 312191 | 1 | 1 |
| 2026-04-28 | ARS | ARS | 0001650664-26-000039 | 001-37687 | 26908566 | 34 | 62066065 | |||
| 2026-04-28 | DEFA14A | DEFA14A | 0001650664-26-000038 | 001-37687 | 26908523 | 34 | 490355 | |||
| 2026-04-28 | DEF 14A | DEF 14A | 0001650664-26-000037 | 001-37687 | 26908486 | 34 | 7935332 | 1 | 1 | |
| 2026-04-07 | 8-K | 8-K | 4.01,9.01 | 0001650664-26-000030 | 001-37687 | 26845288 | 34 | 161641 | 1 | 1 |
| 2026-03-27 | 8-K | 8-K | 7.01,8.01,9.01 | 0001650664-26-000027 | 001-37687 | 26801015 | 34 | 181138 | 1 | 1 |
| 2026-03-26 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-001154 | 005-89319 | 26799916 | 34 | 7072 | |||
| 2026-03-16 | 4 | FORM 4 | 0001650664-26-000023 | 5312 | ||||||
| 2026-03-16 | 4 | FORM 4 | 0001650664-26-000022 | 5293 | ||||||
| 2026-03-16 | 4 | FORM 4 | 0001650664-26-000021 | 5291 | ||||||
| 2026-03-09 | 10-K | 10-K | 0001650664-26-000017 | 001-37687 | 26735820 | 34 | 11935167 | 1 | 1 | |
| 2026-03-09 | 8-K | 8-K | 2.02,9.01 | 0001650664-26-000013 | 001-37687 | 26733151 | 34 | 325361 | 1 | 1 |
| 2026-03-04 | 4 | FORM 4 | 0001650664-26-000009 | 5472 | ||||||
| 2026-03-04 | 4 | FORM 4 | 0001650664-26-000007 | 5342 | ||||||
| 2026-03-04 | 4 | FORM 4 | 0001650664-26-000006 | 5450 | ||||||
| 2026-02-27 | 144 | xsl144X01/primary_doc.xml | 0001650664-26-000002 | 001-37687 | 26700729 | 33 | 4880 | |||
| 2025-12-04 | 4 | FORM 4 | 0001650664-25-000163 | 4986 | ||||||
| 2025-12-04 | 4 | FORM 4 | 0001650664-25-000162 | 5008 | ||||||
| 2025-12-04 | 4 | FORM 4 | 0001650664-25-000161 | 4879 | ||||||
| 2025-12-01 | 144 | xsl144X01/primary_doc.xml | 0001650664-25-000158 | 001-37687 | 251540561 | 33 | 4882 | |||
| 2025-11-10 | 10-Q | 10-Q | 0001650664-25-000156 | 001-37687 | 251466136 | 34 | 5768415 | 1 | 1 | |
| 2025-11-10 | 8-K | 8-K | 2.02,9.01 | 0001650664-25-000153 | 001-37687 | 251464291 | 34 | 318957 | 1 | 1 |
| 2025-10-09 | 8-K | 8-K | 7.01,8.01,9.01 | 0001650664-25-000148 | 001-37687 | 251385443 | 34 | 191230 | 1 | 1 |
| 2025-09-04 | 4 | FORM 4 | 0001650664-25-000143 | 5225 | ||||||
| 2025-09-04 | 4 | FORM 4 | 0001650664-25-000142 | 4880 | ||||||
| 2025-09-04 | 4 | FORM 4 | 0001650664-25-000141 | 5009 | ||||||
| 2025-09-02 | 8-K | 8-K | 7.01,8.01,9.01 | 0001650664-25-000134 | 001-37687 | 251282921 | 34 | 207380 | 1 | 1 |
| 2025-08-29 | 144 | xsl144X01/primary_doc.xml | 0001650664-25-000130 | 001-37687 | 251281449 | 33 | 4883 | |||
| 2025-08-29 | 144 | xsl144X01/primary_doc.xml | 0001650664-25-000128 | 001-37687 | 251281228 | 33 | 5397 | |||
| 2025-08-12 | 10-Q | 10-Q | 0001650664-25-000125 | 001-37687 | 251206724 | 34 | 9663978 | 1 | 1 | |
| 2025-08-12 | 8-K | 8-K | 2.02,9.01 | 0001650664-25-000123 | 001-37687 | 251206545 | 34 | 312966 | 1 | 1 |
| 2025-08-08 | 4 | FORM 4 | 0001650664-25-000118 | 4873 | ||||||
| 2025-08-04 | 4 | FORM 4 | 0001650664-25-000113 | 4984 | ||||||
| 2025-07-30 | 144 | xsl144X01/primary_doc.xml | 0001650664-25-000110 | 001-37687 | 251167252 | 33 | 4811 | |||
| 2025-06-12 | 8-K | 8-K | 7.01,8.01,9.01 | 0001650664-25-000106 | 001-37687 | 251041614 | 34 | 193931 | 1 | 1 |
| 2025-06-10 | 4 | FORM 4 | 0001650664-25-000103 | 13778 | ||||||
| 2025-06-10 | 4 | FORM 4 | 0001650664-25-000102 | 13954 | ||||||
| 2025-06-10 | 4 | FORM 4 | 0001650664-25-000101 | 13691 | ||||||
| 2025-06-10 | 4 | FORM 4 | 0001650664-25-000100 | 13675 | ||||||
| 2025-06-10 | 4 | FORM 4 | 0001650664-25-000099 | 13627 | ||||||
| 2025-06-04 | 4 | FORM 4 | 0001650664-25-000093 | 5342 | ||||||
| 2025-06-04 | 4 | FORM 4 | 0001650664-25-000091 | 5451 | ||||||
| 2025-06-04 | 4 | FORM 4 | 0001650664-25-000089 | 14088 | ||||||
| 2025-06-02 | 144 | xsl144X01/primary_doc.xml | 0001650664-25-000087 | 001-37687 | 251016275 | 33 | 4895 | |||
| 2025-06-02 | 8-K | 8-K | 5.02,5.03,5.07,9.01 | 0001650664-25-000086 | 001-37687 | 251016236 | 34 | 340003 | 1 | 1 |
| 2025-05-14 | 8-K | 8-K | 7.01,8.01,9.01 | 0001650664-25-000081 | 001-37687 | 25942603 | 34 | 211388 | 1 | 1 |
| 2025-05-13 | 8-K | 8-K | 7.01,8.01,9.01 | 0001650664-25-000077 | 001-37687 | 25937092 | 34 | 210894 | 1 | 1 |
| 2025-05-12 | 10-Q | 10-Q | 0001650664-25-000073 | 001-37687 | 25935900 | 34 | 5328826 | 1 | 1 | |
| 2025-05-12 | 8-K | 8-K | 2.02,9.01 | 0001650664-25-000071 | 001-37687 | 25935392 | 34 | 330031 | 1 | 1 |
| 2025-04-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001576419-25-000589 | 005-89319 | 25844526 | 34 | 10794 | |||
| 2025-04-15 | ARS | ARS | 0001650664-25-000064 | 001-37687 | 25840066 | 34 | 23955527 | |||
| 2025-04-15 | DEFA14A | DEFA14A | 0001650664-25-000060 | 001-37687 | 25839711 | 34 | 414504 | |||
| 2025-04-15 | DEF 14A | DEF 14A | 0001650664-25-000058 | 001-37687 | 25839694 | 34 | 8015097 | 1 | 1 | |
| 2025-04-08 | 4 | FORM 4 | 0001650664-25-000052 | 5383 | ||||||
| 2025-04-08 | 3 | FORM 3 | 0001650664-25-000050 | 453181 | ||||||
| 2025-04-04 | PRE 14A | PRE 14A | 0001650664-25-000045 | 001-37687 | 25815453 | 34 | 7996161 | 1 | 1 | |
| 2025-03-27 | 4 | FORM 4 | 0001650664-25-000040 | 7436 | ||||||
| 2025-03-27 | 4 | FORM 4 | 0001650664-25-000037 | 7451 | ||||||
| 2025-03-27 | 4 | FORM 4 | 0001650664-25-000034 | 7430 | ||||||
| 2025-03-21 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000727 | 333-277471 | 25762105 | 33 | 1725 | ||
| 2025-03-20 | 8-K | 8-K | 5.02 | 0001650664-25-000031 | 001-37687 | 25756928 | 34 | 150251 | 1 | 1 |
| 2025-03-05 | POS AM | POS AM | 0001104659-25-020955 | 333-277471 | 25712336 | 33 | 622784 | |||
| 2025-03-05 | 4 | FORM 4 | 0001650664-25-000027 | 448576 | ||||||
| 2025-03-05 | 4 | FORM 4 | 0001650664-25-000026 | 449309 | ||||||
| 2025-03-05 | 4 | FORM 4 | 0001650664-25-000025 | 448996 | ||||||
| 2025-03-05 | S-8 | S-8 | 0001650664-25-000024 | 333-285576 | 25711876 | 33 | 175220 | |||
| 2025-03-05 | 10-K | 10-K | 0001650664-25-000022 | 001-37687 | 25711427 | 34 | 31919737 | 1 | 1 | |
| 2025-03-05 | 8-K | 8-K | 2.02,9.01 | 0001650664-25-000020 | 001-37687 | 25711077 | 34 | 340041 | 1 | 1 |
| 2025-03-05 | POSASR | POSASR | 0001104659-25-020876 | 333-277471 | 25710939 | 33 | 980466 | |||
| 2025-02-28 | 144 | xsl144X01/primary_doc.xml | 0001650664-25-000009 | 001-37687 | 25691176 | 33 | 4900 | |||
| 2025-02-28 | 144 | xsl144X01/primary_doc.xml | 0001650664-25-000007 | 001-37687 | 25691133 | 33 | 4218 | |||
| 2025-02-28 | 144 | xsl144X01/primary_doc.xml | 0001650664-25-000005 | 001-37687 | 25691047 | 33 | 4231 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-000880 | 005-89319 | 25623545 | 34 | 11224 | |||
| 2025-01-13 | 8-K | 8-K | 2.02,7.01,9.01 | 0001650664-25-000003 | 001-37687 | 25525055 | 34 | 214620 | 1 | 1 |
| 2024-12-17 | 8-K | 8-K | 5.02 | 0001650664-24-000144 | 001-37687 | 241555879 | 34 | 148853 | 1 | 1 |
| 2024-12-12 | 8-K | 8-K | 2.05,5.02,7.01,8.01,9.01 | 0001650664-24-000141 | 001-37687 | 241544860 | 34 | 213081 | 1 | 1 |
| 2024-12-10 | 8-K | 8-K | 5.03,7.01,9.01 | 0001650664-24-000138 | 001-37687 | 241536740 | 34 | 8598524 | 1 | 1 |
| 2024-12-05 | 4 | FORM 4 | 0001650664-24-000126 | 5485 | ||||||
| 2024-12-05 | 4 | FORM 4 | 0001650664-24-000124 | 5520 | ||||||
| 2024-11-12 | SC 13G/A | UnitedStates_13G__EditasMedi.txt | 0000932471-24-000974 | 005-89319 | 241446995 | 34 | 6502 | |||
| 2024-11-04 | SC 13G/A | UnitedStates_13G__EditasMedi.txt | 0000932471-24-000483 | 005-89319 | 241421767 | 34 | 5574 | |||
| 2024-11-04 | 10-Q | 10-Q | 0001650664-24-000121 | 001-37687 | 241420768 | 34 | 4551010 | 1 | 1 | |
| 2024-11-04 | 8-K | 8-K | 2.02,9.01 | 0001650664-24-000120 | 001-37687 | 241420762 | 34 | 336070 | 1 | 1 |
| 2024-10-22 | 8-K | 8-K | 2.02,7.01,9.01 | 0001650664-24-000114 | 001-37687 | 241384658 | 34 | 208994 | 1 | 1 |
| 2024-10-17 | SC 13G/A | Editas_Medicine_Inc.htm | 0000093751-24-000835 | 005-89319 | 241376858 | 34 | 55943 | |||
| 2024-10-04 | 8-K | 8-K | 1.01,2.03,7.01,9.01 | 0001650664-24-000111 | 001-37687 | 241352897 | 34 | 195357 | 1 | 1 |
| 2024-09-06 | 4 | FORM 4 | 0001650664-24-000105 | 5520 | ||||||
| 2024-09-06 | 4 | FORM 4 | 0001650664-24-000103 | 5485 | ||||||
| 2024-08-29 | 144 | xsl144X01/primary_doc.xml | 0001650664-24-000100 | 001-37687 | 241264005 | 33 | 4901 | |||
| 2024-08-29 | 144 | xsl144X01/primary_doc.xml | 0001650664-24-000099 | 001-37687 | 241263956 | 33 | 5425 | |||
| 2024-08-07 | 10-Q | 10-Q | 0001650664-24-000097 | 001-37687 | 241183853 | 34 | 4375571 | 1 | 1 | |
| 2024-08-07 | 8-K | 8-K | 2.02,9.01 | 0001650664-24-000094 | 001-37687 | 241181390 | 34 | 308525 | 1 | 1 |
| 2024-07-26 | 4 | FORM 4 | 0001650664-24-000090 | 4992 | ||||||
| 2024-07-22 | 4 | FORM 4 | 0001650664-24-000087 | 5517 | ||||||
| 2024-07-18 | 144 | xsl144X01/primary_doc.xml | 0001650664-24-000084 | 001-37687 | 241125762 | 33 | 4844 | |||
| 2024-07-18 | 144 | xsl144X01/primary_doc.xml | 0001650664-24-000082 | 001-37687 | 241124958 | 33 | 4234 | |||
| 2024-07-10 | SC 13G/A | Editas_Medicine_Inc.txt | 0000093751-24-000653 | 005-89319 | 241108639 | 34 | 8465 | |||
| 2024-06-27 | 8-K | 8-K | 5.02 | 0001650664-24-000081 | 001-37687 | 241080180 | 34 | 146283 | 1 | 1 |
| 2024-06-14 | 8-K | 8-K | 7.01,8.01,9.01 | 0001650664-24-000078 | 001-37687 | 241043009 | 34 | 250903 | 1 | 1 |
| 2024-06-06 | 4 | FORM 4 | 0001650664-24-000076 | 5012 | ||||||
| 2024-06-06 | 4 | FORM 4 | 0001650664-24-000075 | 5047 | ||||||
| 2024-06-03 | 4 | FORM 4 | 0001650664-24-000072 | 5220 | ||||||
| 2024-06-03 | 4 | FORM 4 | 0001650664-24-000071 | 5267 | ||||||
| 2024-06-03 | 4 | FORM 4 | 0001650664-24-000070 | 5265 | ||||||
| 2024-06-03 | 4 | FORM 4 | 0001650664-24-000068 | 5259 | ||||||
| 2024-06-03 | 4 | FORM 4 | 0001650664-24-000060 | 5259 | ||||||
| 2024-06-03 | 4 | FORM 4 | 0001650664-24-000058 | 5265 | ||||||
| 2024-06-03 | 4 | FORM 4 | 0001650664-24-000056 | 5289 | ||||||
| 2024-06-03 | 4 | FORM 4 | 0001650664-24-000054 | 5228 | ||||||
| 2024-05-31 | 144 | xsl144X01/primary_doc.xml | 0001650664-24-000052 | 001-37687 | 241010057 | 33 | 4904 | |||
| 2024-05-31 | 144 | xsl144X01/primary_doc.xml | 0001650664-24-000051 | 001-37687 | 241010036 | 33 | 4833 | |||
| 2024-05-31 | 8-K | 8-K | 5.07 | 0001650664-24-000050 | 001-37687 | 241009912 | 34 | 168279 | 1 | 1 |
| 2024-05-22 | 4 | FORM 4 | 0001650664-24-000044 | 4997 | ||||||
| 2024-05-17 | 144 | xsl144X01/primary_doc.xml | 0001650664-24-000041 | 001-37687 | 24960362 | 33 | 4221 | |||
| 2024-05-14 | 4 | FORM 4 | 0001650664-24-000039 | 4957 | ||||||
| 2024-05-08 | 10-Q | 10-Q | 0001650664-24-000037 | 001-37687 | 24926528 | 34 | 4099702 | 1 | 1 | |
| 2024-05-08 | 8-K | 8-K | 2.02,9.01 | 0001650664-24-000034 | 001-37687 | 24924219 | 34 | 310570 | 1 | 1 |
| 2024-04-16 | DEFA14A | DEFA14A | 0001650664-24-000028 | 001-37687 | 24848169 | 34 | 376062 | |||
| 2024-04-16 | DEF 14A | DEF 14A | 0001650664-24-000025 | 001-37687 | 24848127 | 34 | 8590105 | 1 | 1 | |
| 2024-04-10 | SC 13G/A | Editas_Medicine_Inc.txt | 0000093751-24-000574 | 005-89319 | 24834393 | 34 | 10340 | |||
| 2024-03-05 | 4 | FORM 4 | 0001650664-24-000019 | 9132 | ||||||
| 2024-03-05 | 4 | FORM 4 | 0001650664-24-000017 | 9122 | ||||||
| 2024-03-05 | 4 | FORM 4 | 0001650664-24-000015 | 13085 | ||||||
| 2024-03-05 | 4 | FORM 4 | 0001650664-24-000013 | 13124 | ||||||
| 2024-03-04 | 144 | xsl144X01/primary_doc.xml | 0001650664-24-000011 | 001-37687 | 24716852 | 33 | 4301 | |||
| 2024-02-28 | S-3ASR | S-3ASR | 0001628280-24-007660 | 333-277471 | 24696835 | 33 | 2236339 | |||
| 2024-02-28 | S-8 | S-8 | 0001628280-24-007619 | 333-277459 | 24696201 | 33 | 158979 | |||
| 2024-02-28 | 10-K | 10-K | 0001650664-24-000008 | 001-37687 | 24695496 | 34 | 9578415 | 1 | 1 | |
| 2024-02-28 | 8-K | 8-K | 2.02,9.01 | 0001650664-24-000006 | 001-37687 | 24690140 | 34 | 238135 | 1 | 1 |
| 2024-02-14 | SC 13G/A | deeptrack-edit123123a1.htm | 0001172661-24-000916 | 005-89319 | 24632631 | 34 | 103002 | |||
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-020817 | 005-89319 | 24628446 | 34 | 12994 | |||
| 2024-01-24 | SC 13G/A | us28106w1036_012424.txt | 0001086364-24-002241 | 005-89319 | 24555797 | 34 | 13581 | |||
| 2024-01-10 | SC 13G/A | Editas_Medicine_Inc.txt | 0000093751-24-000017 | 005-89319 | 24525045 | 34 | 8457 | |||
| 2023-12-13 | 8-K | 8-K | 7.01,8.01,9.01 | 0001650664-23-000038 | 001-37687 | 231483073 | 34 | 698086 | 1 | 1 |
| 2023-12-11 | 8-K | 8-K | 7.01,8.01,9.01 | 0001650664-23-000034 | 001-37687 | 231478449 | 34 | 1500984 | 1 | 1 |
| 2023-12-07 | 4 | FORM 4 | 0001650664-23-000029 | 5429 | ||||||
| 2023-11-22 | 8-K | 8-K | 5.02,9.01 | 0001650664-23-000026 | 001-37687 | 231433519 | 34 | 269789 | 1 | 1 |
| 2023-11-16 | 4 | FORM 4 | 0001650664-23-000022 | 4958 | ||||||
| 2023-11-09 | 4 | FORM 4 | 0001650664-23-000019 | 4955 | ||||||
| 2023-11-03 | 10-Q | 10-Q | 0001650664-23-000017 | 001-37687 | 231376254 | 34 | 8334821 | 1 | 1 | |
| 2023-11-03 | 8-K | 8-K | 2.02,9.01 | 0001650664-23-000014 | 001-37687 | 231374471 | 34 | 237458 | 1 | 1 |
| 2023-10-10 | 8-K | 8-K | 5.02 | 0001650664-23-000005 | 001-37687 | 231317966 | 34 | 153362 | 1 | 1 |
| 2023-09-07 | 4 | FORM 4 | 0001650664-23-000002 | 4956 | ||||||
| 2023-08-15 | 4 | xslF345X05/form4-08152023_040803.xml | 0001415889-23-012264 | 4874 | ||||||
| 2023-08-10 | 4 | xslF345X05/form4-08102023_040848.xml | 0001415889-23-012049 | 4871 | ||||||
| 2023-08-04 | SC 13G | deeptrack-edit072623.htm | 0001172661-23-002763 | 005-89319 | 231144253 | 34 | 102877 | |||
| 2023-08-02 | 10-Q | 10-Q | 0001558370-23-012936 | 001-37687 | 231136194 | 34 | 5844088 | 1 | 1 | |
| 2023-08-02 | 8-K | 8-K | 2.02,9.01 | 0001558370-23-012810 | 001-37687 | 231133716 | 34 | 262234 | 1 | 1 |
| 2023-07-25 | 4 | xslF345X05/form4-07252023_040701.xml | 0001415889-23-011455 | 7236 | ||||||
| 2023-07-25 | 3 | xslF345X02/form3-07252023_080727.xml | 0001415889-23-011454 | 12541 | ||||||
| 2023-07-21 | 4 | xslF345X05/form4-07212023_040701.xml | 0001415889-23-011382 | 4880 | ||||||
| 2023-06-15 | 8-K | 8-K | 1.01,8.01,9.01 | 0001558370-23-011141 | 001-37687 | 231017808 | 34 | 489446 | 1 | 1 |
| 2023-06-15 | 424B5 | 424B5 | 0001104659-23-071618 | 333-253715 | 231017646 | 33 | 858682 | |||
| 2023-06-14 | 424B5 | 424B5 | 0001104659-23-071267 | 333-253715 | 231015120 | 33 | 823890 | |||
| 2023-06-09 | 8-K | 8-K | 7.01,8.01,9.01 | 0001558370-23-010931 | 001-37687 | 231003776 | 34 | 291891 | 1 | 1 |
| 2023-06-07 | 4 | xslF345X04/form4-06072023_040605.xml | 0001415889-23-009369 | 5314 | ||||||
| 2023-06-07 | 4 | xslF345X04/form4-06072023_040602.xml | 0001415889-23-009368 | 5339 | ||||||
| 2023-06-05 | 4 | xslF345X04/form4-06052023_040609.xml | 0001415889-23-009232 | 5198 | ||||||
| 2023-06-05 | 4 | xslF345X04/form4-06052023_040621.xml | 0001415889-23-009236 | 5232 | ||||||
| 2023-06-05 | 4 | xslF345X04/form4-06052023_040625.xml | 0001415889-23-009237 | 5202 | ||||||
| 2023-06-05 | 4 | xslF345X04/form4-06052023_040619.xml | 0001415889-23-009234 | 5170 | ||||||
| 2023-06-05 | 4 | xslF345X04/form4-06052023_040604.xml | 0001415889-23-009231 | 5202 | ||||||
| 2023-06-05 | 4 | xslF345X04/form4-06052023_040614.xml | 0001415889-23-009233 | 5164 | ||||||
| 2023-06-05 | 4 | xslF345X04/form4-06052023_040602.xml | 0001415889-23-009230 | 5208 | ||||||
| 2023-06-05 | 8-K | 8-K | 5.07 | 0001558370-23-010811 | 001-37687 | 23992640 | 34 | 166140 | 1 | 1 |
| 2023-06-02 | 144 | xsl144X01/primary_doc.xml | 0001415889-23-009115 | 001-37687 | 23989573 | 33 | 4535 | |||
| 2023-05-18 | 4 | xslF345X04/form4-05182023_090554.xml | 0001415889-23-008293 | 7236 | ||||||
| 2023-05-18 | 3 | xslF345X02/form3-05182023_090528.xml | 0001415889-23-008291 | 12530 | ||||||
| 2023-05-17 | 8-K | 8-K | 5.02 | 0001558370-23-010139 | 001-37687 | 23932166 | 34 | 152789 | 1 | 1 |
| 2023-05-15 | 4 | xslF345X04/form4-05152023_040503.xml | 0001415889-23-007990 | 4920 | ||||||
| 2023-05-15 | 4 | xslF345X04/form4-05152023_040501.xml | 0001415889-23-007989 | 4870 | ||||||
| 2023-05-11 | 144 | xsl144X01/primary_doc.xml | 0001415889-23-007832 | 001-37687 | 23912651 | 33 | 5808 | |||
| 2023-05-11 | 4 | xslF345X04/form4-05112023_040501.xml | 0001415889-23-007816 | 5359 | ||||||
| 2023-05-05 | 10-Q | 10-Q | 0001558370-23-008308 | 001-37687 | 23894051 | 34 | 4917318 | 1 | 1 | |
| 2023-05-05 | 8-K | 8-K | 2.02,9.01 | 0001558370-23-008190 | 001-37687 | 23891219 | 34 | 324668 | 1 | 1 |
| 2023-04-18 | ARS | ARS | 0001104659-23-046740 | 001-37687 | 23827255 | 34 | 5039491 | |||
| 2023-04-18 | DEFA14A | DEFA14A | 0001104659-23-046738 | 001-37687 | 23827235 | 34 | 374618 | |||
| 2023-04-18 | DEF 14A | FORM DEF 14A | 0001104659-23-046732 | 001-37687 | 23827194 | 34 | 10681511 | 1 | 1 | |
| 2023-04-13 | 8-K | 8-K | 5.02 | 0001558370-23-005886 | 001-37687 | 23819081 | 34 | 151389 | 1 | 1 |
| 2023-04-13 | 4 | xslF345X04/form4-04132023_080436.xml | 0001415889-23-006521 | 5309 | ||||||
| 2023-04-13 | 3 | xslF345X02/form3-04132023_080428.xml | 0001415889-23-006520 | 12714 | ||||||
| 2023-03-14 | 8-K | 8-K | 5.02,5.03,9.01 | 0001558370-23-003731 | 001-37687 | 23731664 | 34 | 379845 | 1 | 1 |
| 2023-03-06 | 4 | xslF345X03/form4-03062023_040309.xml | 0001415889-23-004315 | 9129 | ||||||
| 2023-03-06 | 4 | xslF345X03/form4-03062023_040307.xml | 0001415889-23-004314 | 7184 | ||||||
| 2023-03-06 | 4 | xslF345X03/form4-03062023_040304.xml | 0001415889-23-004313 | 7168 | ||||||
| 2023-03-06 | 4 | xslF345X03/form4-03062023_040302.xml | 0001415889-23-004312 | 9078 | ||||||
| 2023-02-22 | S-8 | S-8 | 0001558370-23-001769 | 333-269917 | 23653934 | 33 | 179931 | |||
| 2023-02-22 | 10-K | 10-K | 0001558370-23-001764 | 001-37687 | 23653636 | 34 | 10278275 | 1 | 1 | |
| 2023-02-22 | 8-K | 8-K | 2.02,9.01 | 0001558370-23-001684 | 001-37687 | 23650472 | 34 | 384741 | 1 | 1 |
| 2023-02-15 | 4 | xslF345X03/form4-02152023_040213.xml | 0001415889-23-002604 | 4879 | ||||||
| 2023-02-15 | 4 | xslF345X03/form4-02152023_040208.xml | 0001415889-23-002603 | 4894 | ||||||
| 2023-02-15 | 4 | xslF345X03/form4-02152023_040201.xml | 0001415889-23-002602 | 4844 | ||||||
| 2023-02-09 | 4 | xslF345X03/form4-02092023_040202.xml | 0001415889-23-002218 | 4841 | ||||||
| 2023-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-23-015840 | 005-89319 | 23603006 | 34 | 12939 | |||
| 2023-02-03 | SC 13G/A | Editas_Medicine_Inc.txt | 0000093751-23-000191 | 005-89319 | 23585905 | 34 | 10304 | |||
| 2023-01-26 | SC 13G/A | us28106w1036_012623.txt | 0001306550-23-004464 | 005-89319 | 23554708 | 34 | 13382 | |||
| 2023-01-20 | SC 13G/A | us28106w1036_012023.txt | 0001306550-23-001138 | 005-89319 | 23540665 | 34 | 13358 | |||
| 2023-01-12 | 4 | xslF345X03/form4-01122023_040101.xml | 0001415889-23-000875 | 5358 | ||||||
| 2023-01-09 | 8-K | 8-K | 5.02 | 0001558370-23-000130 | 001-37687 | 23516762 | 34 | 236159 | 1 | 1 |
| 2022-12-06 | 4 | xslF345X03/form4-12062022_041206.xml | 0001415889-22-012132 | 4892 | ||||||
| 2022-12-06 | 4 | xslF345X03/form4-12062022_041201.xml | 0001415889-22-012131 | 4853 | ||||||
| 2022-12-06 | 8-K | 8-K | 8.01,9.01 | 0001558370-22-018383 | 001-37687 | 221446663 | 34 | 276429 | 1 | 1 |
| 2022-11-17 | 8-K | 8-K | 8.01,9.01 | 0001558370-22-018016 | 001-37687 | 221396841 | 34 | 189081 | 1 | 1 |
| 2022-11-09 | 4 | xslF345X03/form4-11092022_041141.xml | 0001415889-22-011242 | 4853 | ||||||
| 2022-11-02 | 10-Q | 10-Q | 0001558370-22-016012 | 001-37687 | 221354611 | 34 | 5608141 | 1 | 1 | |
| 2022-11-02 | 8-K | 8-K | 2.02,9.01 | 0001558370-22-015898 | 001-37687 | 221352229 | 34 | 373169 | 1 | 1 |
| 2022-10-07 | SC 13G/A | us28106w1036_100622.txt | 0000834237-22-010826 | 005-89319 | 221300514 | 34 | 13375 | |||
| 2022-09-08 | 4 | xslF345X03/form4-09082022_040910.xml | 0001415889-22-009449 | 4894 | ||||||
| 2022-09-08 | 4 | xslF345X03/form4-09082022_040901.xml | 0001415889-22-009448 | 4856 | ||||||
| 2022-08-10 | 4 | xslF345X03/form4-08102022_040801.xml | 0001415889-22-008463 | 5322 | ||||||
| 2022-08-03 | 10-Q | 10-Q | 0001558370-22-011904 | 001-37687 | 221133112 | 34 | 5690073 | 1 | 1 | |
| 2022-08-03 | 8-K | 8-K | 2.02,9.01 | 0001558370-22-011740 | 001-37687 | 221130842 | 34 | 299811 | 1 | 1 |
| 2022-07-20 | 4 | xslF345X03/form4-07202022_010742.xml | 0001415889-22-007838 | 7259 | ||||||
| 2022-07-20 | 3 | xslF345X02/form3-07202022_010729.xml | 0001415889-22-007837 | 11292 | ||||||
| 2022-07-11 | SC 13G/A | EDITAS_MEDICINE_INC.txt | 0000093751-22-000569 | 005-89319 | 221076510 | 34 | 10260 | |||
| 2022-06-16 | 4 | xslF345X03/form4-06162022_040601.xml | 0001415889-22-006631 | 4911 | ||||||
| 2022-06-13 | 4 | xslF345X03/form4-06132022_040635.xml | 0001415889-22-006494 | 5202 | ||||||
| 2022-06-13 | 4 | xslF345X03/form4-06132022_040621.xml | 0001415889-22-006492 | 5141 | ||||||
| 2022-06-13 | 4 | xslF345X03/form4-06132022_040629.xml | 0001415889-22-006493 | 5172 | ||||||
| 2022-06-13 | 4 | xslF345X03/form4-06132022_040616.xml | 0001415889-22-006491 | 5134 | ||||||
| 2022-06-13 | 4 | xslF345X03/form4-06132022_040611.xml | 0001415889-22-006490 | 5179 | ||||||
| 2022-06-13 | 4 | xslF345X03/form4-06132022_040601.xml | 0001415889-22-006488 | 5178 | ||||||
| 2022-06-13 | 4 | xslF345X03/form4-06132022_040606.xml | 0001415889-22-006489 | 5171 | ||||||
| 2022-06-13 | 8-K | 8-K | 5.07 | 0001558370-22-009970 | 001-37687 | 221011779 | 34 | 175943 | 1 | 1 |
| 2022-06-06 | 4 | xslF345X03/form4-06062022_010614.xml | 0001415889-22-006162 | 4882 | ||||||
| 2022-06-06 | 4 | xslF345X03/form4-06062022_010617.xml | 0001415889-22-006161 | 4920 | ||||||
| 2022-06-06 | 4 | xslF345X03/form4-06062022_010612.xml | 0001415889-22-006159 | 7225 | ||||||
| 2022-06-06 | 3 | xslF345X02/form3-06062022_010613.xml | 0001415889-22-006158 | 10625 | ||||||
| 2022-05-11 | 4 | xslF345X03/form4-05112022_040501.xml | 0001415889-22-004837 | 5318 | ||||||
| 2022-05-04 | 10-Q | 10-Q | 0001558370-22-007066 | 001-37687 | 22892046 | 34 | 5017251 | 1 | 1 | |
| 2022-05-04 | 8-K | 8-K | 2.02,9.01 | 0001558370-22-006937 | 001-37687 | 22889772 | 34 | 283324 | 1 | 1 |
| 2022-04-26 | DEFA14A | DEFA14A | 0001104659-22-050348 | 001-37687 | 22854576 | 34 | 645970 | |||
| 2022-04-26 | DEF 14A | DEF 14A | 0001104659-22-050341 | 001-37687 | 22854513 | 34 | 3107553 | |||
| 2022-04-18 | 4 | xslF345X03/form4-04182022_040401.xml | 0001415889-22-004098 | 5314 | ||||||
| 2022-04-14 | 8-K | 8-K | 5.02 | 0001558370-22-005418 | 001-37687 | 22826014 | 34 | 156216 | 1 | 1 |
| 2022-04-04 | 4 | xslF345X03/form4-04042022_040401.xml | 0001415889-22-003709 | 6759 | ||||||
| 2022-03-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-22-031862 | 005-89319 | 22724046 | 34 | 12932 | |||
| 2022-03-07 | 4 | xslF345X03/form4-03072022_040308.xml | 0001415889-22-002656 | 4851 | ||||||
| 2022-03-07 | 4 | xslF345X03/form4-03072022_040301.xml | 0001415889-22-002655 | 4889 | ||||||
| 2022-02-24 | S-8 | S-8 | 0001558370-22-001958 | 333-262977 | 22671883 | 33 | 168413 | |||
| 2022-02-24 | 10-K | 10-K | 0001558370-22-001950 | 001-37687 | 22671784 | 34 | 10128405 | 1 | 1 | |
| 2022-02-24 | 8-K | 8-K | 2.02,9.01 | 0001558370-22-001821 | 001-37687 | 22666424 | 34 | 297947 | 1 | 1 |
| 2022-02-14 | SC 13G/A | SC13G/A | 0001140361-22-005028 | 005-89319 | 22624449 | 34 | 64990 | |||
| 2022-02-11 | 4 | xslF345X03/form4-02112022_010246.xml | 0001415889-22-001225 | 7206 | ||||||
| 2022-02-11 | 4 | xslF345X03/form4-02112022_010249.xml | 0001415889-22-001224 | 7241 | ||||||
| 2022-02-11 | 4 | xslF345X03/form4-02112022_010242.xml | 0001415889-22-001223 | 7235 | ||||||
| 2022-02-10 | 4 | xslF345X03/form4-02102022_010215.xml | 0001415889-22-001195 | 5319 | ||||||
| 2022-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-22-017029 | 005-89319 | 22607031 | 34 | 12934 | |||
| 2022-02-09 | SC 13G/A | SC 13G/A | 0001104659-22-016148 | 005-89319 | 22605892 | 34 | 40369 | |||
| 2022-02-07 | 8-K | 8-K | 5.02 | 0001558370-22-000862 | 001-37687 | 22597628 | 34 | 147441 | 1 | 1 |
| 2022-02-04 | SC 13G/A | AMENDMENT NO. 3 | 0001214659-22-001842 | 005-89319 | 22590796 | 34 | 67087 | |||
| 2022-02-03 | SC 13G/A | us28106w1036_020322.txt | 0000834237-22-006425 | 005-89319 | 22589201 | 34 | 13343 | |||
| 2022-01-13 | 4 | FORM 4 - | 0001179110-22-000470 | 4821 | ||||||
| 2022-01-04 | 4 | FORM 4 - | 0001179110-22-000112 | 4847 | ||||||
| 2021-12-23 | 4 | FORM 4 - | 0001179110-21-011227 | 4785 | ||||||
| 2021-12-23 | 4 | FORM 4 - | 0001179110-21-011226 | 4799 | ||||||
| 2021-12-23 | 4 | FORM 4 - | 0001179110-21-011225 | 4828 | ||||||
| 2021-12-23 | 4 | FORM 4 - | 0001179110-21-011224 | 4814 | ||||||
| 2021-12-23 | 4 | FORM 4 - | 0001179110-21-011223 | 4674 | ||||||
| 2021-11-15 | 4 | FORM 4 - | 0001179110-21-010113 | 4808 | ||||||
| 2021-11-10 | 4 | FORM 4 - | 0001179110-21-010059 | 4789 | ||||||
| 2021-11-09 | 10-Q | 10-Q | 0001558370-21-015161 | 001-37687 | 211389883 | 34 | 8355050 | 1 | 1 | |
| 2021-11-08 | 8-K | 8-K | 2.02,9.01 | 0001558370-21-014923 | 001-37687 | 211386514 | 34 | 262197 | 1 | 1 |
| 2021-10-28 | 4 | FORM 4 - | 0001179110-21-009688 | 5246 | ||||||
| 2021-10-28 | 3 | FORM 3 - | 0001179110-21-009687 | 8000 | ||||||
| 2021-10-28 | 8-K | 8-K | 5.02 | 0001558370-21-013688 | 001-37687 | 211355361 | 34 | 152605 | 1 | 1 |
| 2021-10-20 | 4 | FORM 4 - | 0001179110-21-009557 | 4849 | ||||||
| 2021-10-15 | CT ORDER | filename1.pdf | 20211015,20211015 | 9999999997-21-005256 | 001-37687 | 211324703 | 34 | 162099 | ||
| 2021-10-04 | 4 | FORM 4 - | 0001179110-21-009149 | 4674 | ||||||
| 2021-09-29 | 8-K | 8-K | 7.01,8.01,9.01 | 0001558370-21-012862 | 001-37687 | 211289561 | 34 | 194706 | 1 | 1 |
| 2021-09-08 | 4 | FORM 4 - | 0001179110-21-008671 | 5219 | ||||||
| 2021-09-08 | 3 | FORM 3 - | 0001179110-21-008670 | 8103 | ||||||
| 2021-09-08 | 8-K | 8-K | 5.02 | 0001558370-21-012312 | 001-37687 | 211242359 | 34 | 153016 | 1 | 1 |
| 2021-08-10 | 4 | FORM 4 - | 0001179110-21-008086 | 8341 | ||||||
| 2021-08-05 | 10-Q | 10-Q | 0001558370-21-010390 | 001-37687 | 211146342 | 34 | 5722950 | 1 | 1 | |
| 2021-08-04 | 8-K | 8-K | 2.02,9.01 | 0001558370-21-010084 | 001-37687 | 211142329 | 34 | 264767 | 1 | 1 |
| 2021-07-30 | 3 | FORM 3 - | 0001179110-21-007765 | 13908 | ||||||
| 2021-07-13 | CT ORDER | filename1.pdf | 20210713,20210713 | 9999999997-21-004079 | 001-37687 | 211086821 | 34 | 121342 | ||
| 2021-06-30 | 4 | FORM 4 - | 0001179110-21-007175 | 8344 | ||||||
| 2021-06-16 | 4 | FORM 4 - | 0001179110-21-006780 | 5263 | ||||||
| 2021-06-16 | 4 | FORM 4 - | 0001179110-21-006778 | 7125 | ||||||
| 2021-06-16 | 3 | FORM 3 - | 0001179110-21-006777 | 7986 | ||||||
| 2021-06-08 | 8-K | 8-K | 5.07 | 0001558370-21-008121 | 001-37687 | 211002335 | 34 | 169146 | 1 | 1 |
| 2021-06-07 | 4 | FORM 4 - | 0001179110-21-006458 | 9470 | ||||||
| 2021-06-07 | 4 | FORM 4 - | 0001179110-21-006454 | 9441 | ||||||
| 2021-06-07 | 4 | FORM 4 - | 0001179110-21-006452 | 9494 | ||||||
| 2021-06-07 | 4 | FORM 4 - | 0001179110-21-006451 | 9478 | ||||||
| 2021-06-07 | 4 | FORM 4 - | 0001179110-21-006450 | 5114 | ||||||
| 2021-05-21 | DEFA14A | DEFA14A | 0001104659-21-070138 | 001-37687 | 21946529 | 34 | 2505897 | |||
| 2021-05-14 | 8-K | FORM 8-K | 1.01,9.01 | 0001104659-21-066941 | 001-37687 | 21925641 | 34 | 482058 | 1 | 1 |
| 2021-05-14 | 424B5 | 424B5 | 0001104659-21-066936 | 333-253715 | 21925608 | 33 | 542308 | |||
| 2021-05-06 | 10-Q | 10-Q | 0001558370-21-006073 | 001-37687 | 21895823 | 34 | 5025917 | 1 | 1 | |
| 2021-05-05 | 8-K | 8-K | 2.02,9.01 | 0001558370-21-005794 | 001-37687 | 21891139 | 34 | 270037 | 1 | 1 |
| 2021-04-20 | DEFA14A | DEFA14A | 0001104659-21-052536 | 001-37687 | 21838042 | 34 | 708690 | |||
| 2021-04-20 | DEF 14A | DEF 14A | 0001104659-21-052527 | 001-37687 | 21838009 | 34 | 2764782 | |||
| 2021-03-23 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-000916 | 275412 | ||||||
| 2021-03-05 | 4 | FORM 4 - | 0001179110-21-002936 | 9149 | ||||||
| 2021-03-04 | 4 | FORM 4 - | 0001179110-21-002870 | 11369 | ||||||
| 2021-03-04 | 4 | FORM 4 - | 0001179110-21-002869 | 11642 | ||||||
| 2021-03-01 | S-8 | S-8 | 0001558370-21-002178 | 333-253716 | 21698367 | 33 | 146535 | |||
| 2021-03-01 | S-3ASR | S-3ASR | 0001104659-21-030025 | 333-253715 | 21698352 | 33 | 1498817 | |||
| 2021-02-26 | 10-K | 10-K | 0001558370-21-001915 | 001-37687 | 21683785 | 34 | 12065769 | 1 | 1 | |
| 2021-02-25 | 8-K | 8-K | 2.02,9.01 | 0001558370-21-001723 | 001-37687 | 21676456 | 34 | 292458 | 1 | 1 |
| 2021-02-23 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-000810 | 276766 | ||||||
| 2021-02-19 | 8-K/A | 8-K/A | 5.02 | 0001558370-21-001289 | 001-37687 | 21655771 | 34 | 151155 | 1 | 1 |
| 2021-02-16 | SC 13G/A | SC 13G/A | 0001104659-21-024181 | 005-89319 | 21639379 | 34 | 43062 | |||
| 2021-02-11 | SC 13G/A | SC 13G/A | 0001140361-21-004348 | 005-89319 | 21620019 | 34 | 67637 | |||
| 2021-02-10 | 4 | FORM 4 - | 0001179110-21-001512 | 5213 | ||||||
| 2021-02-10 | SC 13G/A | SCHEDULE 13G/A | 0001104659-21-017967 | 005-89319 | 21610607 | 34 | 13774 | |||
| 2021-02-08 | 8-K | FORM 8-K | 5.02,9.01 | 0001104659-21-013334 | 001-37687 | 21598611 | 34 | 223895 | 1 | 1 |
| 2021-02-05 | SC 13G/A | AMENDMENT NO. 2 | 0001214659-21-001369 | 005-89319 | 21593351 | 34 | 66725 | |||
| 2021-01-29 | SC 13G/A | us28106w1036_012921.txt | 0000834237-21-003812 | 005-89319 | 21568691 | 34 | 13324 | |||
| 2021-01-21 | 8-K | FORM 8-K | 1.01,8.01,9.01 | 0001104659-21-006336 | 001-37687 | 21542601 | 34 | 471903 | 1 | 1 |
| 2021-01-21 | 424B5 | 424B5 | 0001047469-21-000159 | 333-223596 | 21542567 | 33 | 666310 | |||
| 2021-01-19 | 8-K | FORM 8-K | 2.02,8.01,9.01 | 0001104659-21-005360 | 001-37687 | 21535968 | 34 | 215440 | 1 | 1 |
| 2021-01-19 | 424B5 | 424B5 | 0001047469-21-000132 | 333-223596 | 21535938 | 33 | 662596 | |||
| 2021-01-13 | 4 | FORM 4 - | 0001179110-21-000574 | 4821 | ||||||
| 2021-01-11 | 8-K | FORM 8-K | 5.02,8.01,9.01 | 0001104659-21-002967 | 001-37687 | 21520869 | 34 | 227939 | 1 | 1 |
| 2021-01-11 | 424B7 | 424B7 | 0001104659-21-002964 | 333-223596 | 21520855 | 33 | 34845 | |||
| 2020-12-18 | 4 | FORM 4 - | 0001179110-20-012101 | 5224 | ||||||
| 2020-12-18 | 3 | FORM 3 - | 0001179110-20-012100 | 7961 | ||||||
| 2020-12-18 | 8-K | 8-K | 5.02 | 0001558370-20-014467 | 001-37687 | 201400889 | 34 | 152284 | 1 | 1 |
| 2020-12-17 | 4 | FORM 4 - | 0001179110-20-012070 | 11996 | ||||||
| 2020-12-11 | 4 | FORM 4 - | 0001179110-20-011830 | 8273 | ||||||
| 2020-12-08 | 4 | FORM 4 - | 0001179110-20-011752 | 8734 | ||||||
| 2020-11-10 | 4 | FORM 4 - | 0001179110-20-010969 | 7115 | ||||||
| 2020-11-10 | 3 | FORM 3 - | 0001179110-20-010967 | 8060 | ||||||
| 2020-11-10 | 4 | FORM 4 - | 0001179110-20-010963 | 4761 | ||||||
| 2020-11-06 | 10-Q | 10-Q | 0001558370-20-013022 | 001-37687 | 201292471 | 34 | 7234267 | 1 | 1 | |
| 2020-11-05 | 8-K | 8-K | 2.02,9.01 | 0001558370-20-012865 | 001-37687 | 201290680 | 34 | 256226 | 1 | 1 |
| 2020-10-16 | 4 | FORM 4 - | 0001179110-20-010507 | 4984 | ||||||
| 2020-10-09 | SC 13G/A | SC 13G/A | 0001104659-20-113794 | 005-89319 | 201232780 | 34 | 46429 | |||
| 2020-08-21 | 4 | FORM 4 - | 0001179110-20-009219 | 5213 | ||||||
| 2020-08-19 | 4 | FORM 4 - | 0001179110-20-009170 | 8728 | ||||||
| 2020-08-10 | 4 | FORM 4 - | 0001179110-20-008833 | 10523 | ||||||
| 2020-08-07 | 10-Q | 10-Q | 0001558370-20-009821 | 001-37687 | 201083788 | 34 | 6103809 | 1 | 1 | |
| 2020-08-06 | 8-K | 8-K | 1.01,1.02,2.02,9.01 | 0001558370-20-009648 | 001-37687 | 201081680 | 34 | 263911 | 1 | 1 |
| 2020-07-17 | 4 | FORM 4 - | 0001179110-20-008367 | 4525 | ||||||
| 2020-06-25 | 8-K | FORM 8-K | 1.01,8.01,9.01 | 0001104659-20-076658 | 001-37687 | 20987151 | 34 | 478484 | 1 | 1 |
| 2020-06-25 | 424B5 | 424B5 | 0001047469-20-003852 | 333-239389 | 20987149 | 33 | 486021 | |||
| 2020-06-23 | S-3ASR | S-3ASR | 0001047469-20-003806 | 333-239389 | 20982047 | 33 | 566452 | |||
| 2020-06-15 | 8-K | 8-K | 5.07 | 0001558370-20-007536 | 001-37687 | 20963347 | 34 | 165797 | 1 | 1 |
| 2020-06-12 | 4 | FORM 4 - | 0001179110-20-007280 | 5175 | ||||||
| 2020-06-12 | 4 | FORM 4 - | 0001179110-20-007277 | 5116 | ||||||
| 2020-06-12 | 4 | FORM 4 - | 0001179110-20-007273 | 5109 | ||||||
| 2020-06-12 | 4 | FORM 4 - | 0001179110-20-007265 | 5077 | ||||||
| 2020-06-12 | 4 | FORM 4 - | 0001179110-20-007263 | 5063 | ||||||
| 2020-05-15 | 424B5 | 424B5 | 0001047469-20-003096 | 333-223596 | 20885577 | 33 | 359665 | |||
| 2020-05-15 | 8-K | 8-K | 1.01,9.01 | 0001558370-20-006724 | 001-37687 | 20884960 | 34 | 644847 | 1 | 1 |
| 2020-05-08 | 4 | FORM 4 - | 0001179110-20-005605 | 4784 | ||||||
| 2020-05-08 | 10-Q | 10-Q | 0001558370-20-005883 | 001-37687 | 20858820 | 34 | 5209535 | 1 | 1 | |
| 2020-05-07 | 8-K | 8-K | 2.02,9.01 | 0001558370-20-005548 | 001-37687 | 20854592 | 34 | 271636 | 1 | 1 |
One latest value per concept from companyfacts (323 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 154.34M | 2026-11-06 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 191.38M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 1.17M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001650664-26-000037 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 999,023 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001650664-26-000037 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 23.11 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001650664-26-000037 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 397.52 | 2026-09-09 | S-8 | 2026-09-09 | 0001650664-26-000090 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 397.52 | 2026-09-09 | S-8 | 2026-09-09 | 0001650664-26-000090 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 2.88M | 2026-09-09 | S-8 | 2026-09-09 | 0001650664-26-000090 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-09-09 | S-8 | 2026-09-09 | 0001650664-26-000090 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-08-28 | S-3 | 2026-08-31 | 0001104659-26-103906 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 6.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 4.92M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-04 | 0001650664-24-000121 |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 18.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 88,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | AccruedRentCurrent | Accrued Rent, Current | USD | 18,000 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-03 | 0001558370-17-001340 | |
| us-gaap | AccruedRentNoncurrent | Accrued Rent, Noncurrent | USD | 380,000 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-03 | 0001558370-17-001340 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 27.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -96,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 1.78B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock | Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock | USD | 47,000 | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001558370-19-001364 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 2.57M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 6.87M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | AllowanceForDoubtfulAccountsReceivableCurrent | Accounts Receivable, Allowance for Credit Loss, Current | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 | |
| us-gaap | AllowanceForDoubtfulAccountsReceivableWriteOffs | Accounts Receivable, Allowance for Credit Loss, Writeoff | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | AmortizationOfFinancingCosts | Amortization of Debt Issuance Costs | USD | 62,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-05 | 0001650664-25-000022 |
| us-gaap | AmortizationOfFinancingCostsAndDiscounts | Amortization of Debt Issuance Costs and Discounts | USD | 445,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-03 | 0001558370-17-001340 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 69.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | Assets | Assets | USD | 219.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 201.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 192.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 96,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 190.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | AvailableForSaleSecurities | Available-for-sale Securities | USD | 329.14M | 2017-12-31 | 2017 | FY | 10-K | 2018-03-08 | 0001558370-18-001721 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | USD | 1,000 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-09 | 0001558370-17-006422 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | USD | 76,000 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-08 | 0001558370-18-001721 | |
| us-gaap | AvailableForSaleSecuritiesAmortizedCost | Available-for-sale Securities, Amortized Cost Basis | USD | 329.21M | 2017-12-31 | 2017 | FY | 10-K | 2018-03-08 | 0001558370-18-001721 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value | USD | 174.00M | 2017-12-31 | 2017 | FY | 10-K | 2018-03-08 | 0001558370-18-001721 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 190.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | AvailableForSaleSecuritiesGrossRealizedGainLossNet | Available-for-sale Securities, Gross Realized Gain (Loss) | USD | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-08 | 0001558370-18-001721 |
| us-gaap | BusinessExitCosts1 | Business Exit Costs | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | CapitalLeaseObligationsIncurred | Lease Obligation Incurred | USD | 3.78M | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-05 | 0001558370-23-008308 |
| us-gaap | CapitalLeaseObligationsNoncurrent | Capital Lease Obligations, Noncurrent | USD | 32.42M | 2018-12-31 | 2019 | Q1 | 10-Q | 2019-05-08 | 0001558370-19-004444 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 93.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 146.65M | 2025-12-31 | 2026 | Q2 | 10-Q | 2026-08-05 | 0001650664-26-000083 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | -98.78M | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-08 | 0001558370-17-008429 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 95.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -53.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 23,076 | 2016-02-29 | 2016 | FY | 10-K | 2017-03-03 | 0001558370-17-001340 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 55.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 24.01M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 390.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 153.66M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 97.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 15,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -66.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | ContractsRevenue | Contracts Revenue (Deprecated 2018-01-31) | USD | 13.73M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-08 | 0001558370-18-001721 |
| us-gaap | ContractWithCustomerLiability | Contract with Customer, Liability | USD | 36.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 32.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 4.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | 15.92M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod | Contract with Customer, Performance Obligation Satisfied in Previous Period | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 199.91M | 2016-01-01 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-09 | 0001558370-16-009820 |
| us-gaap | CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption | Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) | USD | 803,000 | 2019-03-31 | 2020 | Q2 | 10-Q | 2020-08-07 | 0001558370-20-009821 | |
| us-gaap | DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction | Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | USD | 20,000 | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-03-03 | 0001558370-17-001340 |
| us-gaap | DebtSecuritiesAvailableForSaleAllowanceForCreditLoss | Debt Securities, Available-for-sale, Allowance for Credit Loss | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 0 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-12 | 0001650664-25-000125 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions | security | 0 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-08 | 0001650664-24-000037 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | USD | 26.60M | 2019-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001558370-20-001476 | |
| us-gaap | DebtSecuritiesAvailableForSaleRealizedGainLoss | Debt Securities, Available-for-sale, Realized Gain (Loss) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | USD | 2,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-04 | 0001650664-24-000121 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions | Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | security | 0 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-12 | 0001650664-25-000073 | |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 0 | 2016-01-01 | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-13 | 0001558370-16-005983 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 4.24M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | -283,000 | 2015-12-31 | 2016 | Q2 | 10-Q | 2016-08-10 | 0001558370-16-007838 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 13.24M | 2017-12-31 | 2017 | FY | 10-K | 2018-03-08 | 0001558370-18-001721 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 94.72M | 2017-12-31 | 2017 | FY | 10-K | 2018-03-08 | 0001558370-18-001721 | |
| us-gaap | DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction | Deferred Tax Assets, Deferred Gain on Sale Leaseback Transaction | USD | 9.10M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001558370-20-001476 | |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 11.71M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 48.08M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 436.44M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 4.24M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 231.98M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration | Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration | USD | 75.50M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-26 | 0001558370-21-001915 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 15.42M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 35.95M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 84.70M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-05 | 0001650664-25-000022 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 7.38M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | USD | 3.48M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 432.20M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 | |
| us-gaap | DeferredTaxLiabilitiesDeferredExpense | Deferred Tax Liabilities, Deferred Expense | USD | 335,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001558370-22-001950 | |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 1.20M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercent | Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay | pure | 0.03 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercentOfMatch | Defined Contribution Plan, Employer Matching Contribution, Percent of Match | pure | 2 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | Depreciation | Depreciation | USD | 1.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.54 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -1.67 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-05 | 0001558370-21-010390 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.54 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.203 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | -0.001 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-05 | 0001650664-25-000022 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.028 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | pure | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-05 | 0001650664-25-000022 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.002 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-05 | 0001650664-25-000022 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.026 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-05 | 0001650664-25-000022 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.022 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 5.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 9.80M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001558370-19-010798 | |
| us-gaap | EquitySecuritiesFvNiRealizedGain | Equity Securities, FV-NI, Realized Gain | USD | 16.37M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-22 | 0001558370-23-001764 |
| us-gaap | EquitySecuritiesFvNiUnrealizedGain | Equity Securities, FV-NI, Unrealized Gain | USD | 13.11M | 2020-01-01 | 2020-09-30 | 2021 | Q3 | 10-Q | 2021-11-09 | 0001558370-21-015161 |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 87,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-03 | 0001558370-17-001340 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings | USD | 87,000 | 2016-01-01 | 2016-06-30 | 2016 | Q2 | 10-Q | 2016-08-10 | 0001558370-16-007838 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements | USD | 376,000 | 2016-01-01 | 2016-06-30 | 2016 | Q2 | 10-Q | 2016-08-10 | 0001558370-16-007838 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | USD | 289,000 | 2015-12-31 | 2016 | Q2 | 10-Q | 2016-08-10 | 0001558370-16-007838 | |
| us-gaap | FinanceLeaseLiabilityNoncurrent | Finance Lease, Liability, Noncurrent | USD | 32.42M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001558370-20-001476 | |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | -111,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 35.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 3.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | ImpairmentOfLongLivedAssetsToBeDisposedOf | Impairment of Long-Lived Assets to be Disposed of | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | IncomeLossFromContinuingOperationsPerBasicAndDilutedShare | Income (Loss) from Continuing Operations, Per Basic and Diluted Share | USD/shares | -0.74 | 2019-10-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-02-26 | 0001558370-21-001915 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 32.52M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -33.58M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 178,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 4.44M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | -9,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 3.54M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 4.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | -7.45M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | -14.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | -8.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | 81.71M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-08 | 0001558370-18-001721 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -4.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentLiabilities | Increase (Decrease) in Other Noncurrent Liabilities | USD | -258,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | 1.27M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-05 | 0001650664-25-000022 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 1.97M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | IncreaseDecreaseInRestrictedCash | Increase (Decrease) in Restricted Cash | USD | 1.62M | 2016-01-01 | 2016-09-30 | 2017 | Q3 | 10-Q | 2017-11-08 | 0001558370-17-008429 |
| us-gaap | InterestExpenseDebt | Interest Expense, Debt | USD | 3.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 5.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 465,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-03 | 0001558370-17-001340 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 13,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-08 | 0001558370-18-001721 |
| us-gaap | InvestmentIncomeNet | Investment Income, Net | USD | 4.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | InvestmentIncomeNetAmortizationOfDiscountAndPremium | Investment Income, Net, Amortization of Discount and Premium | USD | 443,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 1.80M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-02-26 | 0001558370-21-001915 |
| us-gaap | LeaseCost | Lease, Cost | USD | 5.10M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001558370-19-010798 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 20.46M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0001650664-24-000008 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 7.39M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 6.00M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0001650664-24-000008 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 6.00M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-05 | 0001650664-25-000022 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 6.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 7.08M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 1.09M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001558370-19-010798 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 2.36M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 | |
| us-gaap | Liabilities | Liabilities | USD | 134.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 219.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 71.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 57.43M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-05 | 0001650664-25-000022 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 7.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 49.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | LossOnContractTermination | Loss on Contract Termination | USD | 4.80M | 2025-04-01 | 2025-06-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | MarketableSecurities | Marketable Securities | USD | 460.81M | 2019-12-31 | 2020 | FY | 10-K | 2021-02-26 | 0001558370-21-001915 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 97.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | MarketableSecuritiesNoncurrent | Marketable Securities, Noncurrent | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-05 | 0001650664-25-000022 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 117.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 97.09M | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-15 | 0001558370-17-004338 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -96.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -656,000 | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-15 | 0001558370-17-004338 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -73.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | 69.79M | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-15 | 0001558370-17-004338 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -66.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -220.43M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-22 | 0001558370-23-001764 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | -220.43M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-22 | 0001558370-23-001764 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 1.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | NotesIssued1 | Notes Issued | USD | 12.50M | 2018-01-01 | 2018-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001558370-19-010798 |
| us-gaap | NotesPayable | Notes Payable | USD | 7.50M | 2017-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001558370-19-001364 | |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | OperatingCostsAndExpenses | Operating Costs and Expenses | USD | 35.49M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-04 | 0001558370-18-004024 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 92.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -67.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 14.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 18.10M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 6.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 7.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 5.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 12.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 29.06M | 2016-12-31 | 2016 | FY | 10-K | 2017-03-03 | 0001558370-17-001340 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 3.96M | 2016-12-31 | 2016 | FY | 10-K | 2017-03-03 | 0001558370-17-001340 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 4.36M | 2016-12-31 | 2016 | FY | 10-K | 2017-03-03 | 0001558370-17-001340 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 4.26M | 2016-12-31 | 2016 | FY | 10-K | 2017-03-03 | 0001558370-17-001340 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 4.16M | 2016-12-31 | 2016 | FY | 10-K | 2017-03-03 | 0001558370-17-001340 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 4.05M | 2016-12-31 | 2016 | FY | 10-K | 2017-03-03 | 0001558370-17-001340 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 8.27M | 2016-12-31 | 2016 | FY | 10-K | 2017-03-03 | 0001558370-17-001340 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.092 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 147.80M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001558370-19-001364 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 376,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | OtherAssetsMiscellaneousCurrent | Other Assets, Miscellaneous, Current | USD | 2.87M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001558370-19-001364 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 2.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -96,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -6,000 | 2023-04-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-02 | 0001558370-23-012936 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 2.68M | 2019-12-31 | 2020 | FY | 10-K | 2021-02-26 | 0001558370-21-001915 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 2.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | 17,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -97,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | OtherRestructuringCosts | Other Restructuring Costs | USD | -1.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | PaymentsOfDebtExtinguishmentCosts | Payment for Debt Extinguishment or Debt Prepayment Cost | USD | 80,000 | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-08 | 0001558370-18-001721 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 1.76M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-05 | 0001650664-25-000022 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 300,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-02-22 | 0001558370-23-001764 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 116.68M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 198,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | PreferredStockNoParValue | Preferred Stock, No Par Value | USD/shares | 0 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-02 | 0001558370-22-016012 | |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 5.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 4.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 2.92M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001558370-19-001364 | |
| us-gaap | ProceedsFromDebtNetOfIssuanceCosts | Proceeds from Debt, Net of Issuance Costs | USD | 1.50M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-08 | 0001558370-18-001721 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 1.20B | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 116.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | ProceedsFromIssuanceOfDebt | Proceeds from Issuance of Debt | USD | 57.00M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-05 | 0001650664-25-000022 |
| us-gaap | ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock | Proceeds from Issuance of Redeemable Convertible Preferred Stock | USD | 141.71M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-08 | 0001558370-18-001721 |
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 6,000 | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-08 | 0001558370-18-001721 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 20.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | ProceedsFromSaleOfMachineryAndEquipment | Proceeds from Sale of Machinery and Equipment | USD | 156,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 187,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -89.33M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-02 | 0001558370-23-012936 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 29.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 2.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | ReceivablesNetCurrent | Receivables, Net, Current | USD | 7.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | RelatedPartyTransactionAmountsOfTransaction | Related Party Transaction, Amounts of Transaction | USD | 0 | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-15 | 0001558370-17-004338 |
| us-gaap | RepaymentsOfDebt | Repayments of Debt | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | RepaymentsOfDebtAndCapitalLeaseObligations | Repayments of Debt and Lease Obligation | USD | 857,000 | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-02-26 | 0001558370-21-001915 |
| us-gaap | RepaymentsOfLongTermDebt | Repayments of Long-term Debt | USD | 2.00M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-08 | 0001558370-18-001721 |
| us-gaap | RepaymentsOfNotesPayable | Repayments of Notes Payable | USD | 600,000 | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001558370-20-001476 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 58.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | ResearchAndDevelopmentInProcess | Research and Development in Process | USD | 27.50M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-22 | 0001558370-23-001764 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 2.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 2.67M | 2025-12-31 | 2026 | Q2 | 10-Q | 2026-08-05 | 0001650664-26-000083 | |
| us-gaap | RestrictedCashAndCashEquivalentsAtCarryingValue | Restricted Cash and Cash Equivalents, Current | USD | 3.90M | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001558370-22-001950 | |
| us-gaap | RestrictedCashAndCashEquivalentsNoncurrent | Restricted Cash and Cash Equivalents, Noncurrent | USD | 2.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 | |
| us-gaap | RestrictedCashAndInvestmentsCurrent | Restricted Cash and Investments, Current | USD | 320,000 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-08 | 0001558370-18-001721 | |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminated | Restructuring and Related Cost, Number of Positions Eliminated | position | 180 | 2024-12-11 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | pure | 0.65 | 2024-12-11 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 79.17M | 2024-12-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-12 | 0001650664-25-000125 |
| us-gaap | RestructuringReserveAcceleratedDepreciation | Restructuring and Related Cost, Accelerated Depreciation | USD | 1.80M | 2025-04-01 | 2025-06-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | RestructuringReserveCurrent | Restructuring Reserve, Current | USD | 30.54M | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-12 | 0001650664-25-000073 | |
| us-gaap | RestructuringSettlementAndImpairmentProvisions | Restructuring, Settlement and Impairment Provisions | USD | -1.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -1.70B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 25.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | RevenueFromContractWithCustomerIncludingAssessedTax | Revenue from Contract with Customer, Including Assessed Tax | USD | 31.94M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001558370-19-001364 |
| us-gaap | Revenues | Revenues | USD | 2.07M | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-08 | 0001558370-19-004444 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 793,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | SeveranceCosts1 | Severance Costs | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 6.87M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares | 51,182 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001558370-19-010798 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | USD/shares | 21.4 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001558370-19-010798 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 445,126 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001558370-19-010798 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 21.94 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001558370-19-010798 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 586,892 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001558370-19-010798 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | USD/shares | 24.2 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001558370-19-010798 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares | 77,052 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001558370-19-010798 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | USD/shares | 26.47 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001558370-19-010798 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 13.24M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001558370-19-010798 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 2.39M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001558370-19-010798 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 21.5 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001558370-19-010798 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 587,594 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 546,799 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001558370-19-010798 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 28.15 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001558370-19-010798 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 1.50M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001558370-19-010798 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 14.90M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001558370-19-010798 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 5.14M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001558370-19-010798 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 24.69 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001558370-19-010798 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 61.94M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-04 | 0001558370-18-004024 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 5.30M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-04 | 0001558370-18-004024 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 22.61 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-04 | 0001558370-18-004024 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 11.46 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001558370-19-010798 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 16.31 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 24.3 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001558370-19-010798 |
| us-gaap | StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants | USD | 37.04M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-08 | 0001558370-18-001721 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 84.52M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.385 | 2016-01-15 | 2016 | FY | 10-K | 2017-03-03 | 0001558370-17-001340 | |
| us-gaap | StockIssued1 | Stock Issued | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities | Stock Issued During Period, Shares, Conversion of Convertible Securities | shares | 24.93M | 2016-02-01 | 2016-02-29 | 2016 | FY | 10-K | 2017-03-03 | 0001558370-17-001340 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 6.90M | 2020-06-01 | 2020-06-30 | 2020 | FY | 10-K | 2021-02-26 | 0001558370-21-001915 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 502,234 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001558370-19-010798 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments | Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments | USD | 199.96M | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001558370-19-001364 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 228,000 | 2025-04-01 | 2025-06-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForServices | Stock Issued During Period, Value, Issued for Services | USD | 27.50M | 2021-01-01 | 2021-03-31 | 2022 | Q3 | 10-Q | 2022-11-02 | 0001558370-22-016012 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 116.88M | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | StockIssuedDuringPeriodValuePurchaseOfAssets | Stock Issued During Period, Value, Purchase of Assets | USD | 1.94M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-02-26 | 0001558370-21-001915 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | USD | 0 | 2024-07-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-04 | 0001650664-24-000121 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 590,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-05 | 0001650664-25-000022 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 151,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | StraightLineRentAdjustments | Straight Line Rent Adjustments | USD | 310,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-03 | 0001558370-17-001340 |
| us-gaap | TemporaryEquityAccretionToRedemptionValue | Temporary Equity, Accretion to Redemption Value | USD | 47,000 | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001558370-19-001364 |
| us-gaap | TemporaryEquityAccretionToRedemptionValueAdjustment | Temporary Equity, Accretion to Redemption Value, Adjustment | USD | 47,000 | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001558370-19-001364 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 17.10M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 | |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 1.42M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 43.20M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 2.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001650664-26-000017 |
| us-gaap | WarrantsAndRightsOutstanding | Warrants and Rights Outstanding | USD | 289,000 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-03 | 0001558370-17-001340 | |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 123.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 58.61M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-26 | 0001558370-21-001915 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 123.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001650664-26-000103 |